Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > EGFR > Patritumab (Anti-ERBB3 / HER3)

Patritumab (Anti-ERBB3 / HER3)

ChemLeader 95+%

Catalog No：CLA1295 CAS No.：1262787-83-6 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$550.00	Visible after login	- +
5 mg	3-5days	$1200.00	Visible after login	- +
10 mg	3-5days	$1800.00	Visible after login	- +
50 mg	3-5days	$6000.00	Visible after login	- +
100 mg	3-5days	$12000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Patritumab (Anti-ERBB3 / HER3)
CAS	1262787-83-6
Storage condition	Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.

Product details

Patritumab (Anti-ERBB3 / HER3) is a neutralizing monoclonal antibody targeting ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors. MW: 145.5 KD.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1295

Patritumab (Anti-ERBB3 / HER3)

1262787-83-6 95+%